None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients: Patients diagnosed with Vestibular Migraine (VM) according to ICHD-3 criteria 2. Controls: Individuals with no history of VM or other vestibular disorders 3. Adults aged 20 to 70 years 4. Ability to understand the study procedures and communicate effectively 5. Provision of voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1. Presence of abnormal findings in neurological or neuroimaging examinations 2. History of treatment for other diseases that may cause vestibular dysfunction 3. Clinically significant systemic diseases (e.g., cerebrovascular, cardiopulmonary, hepatic, renal, malignancy, or psychiatric disorders) 4. Pregnant women or women with the possibility of pregnancy within 2 months of consent 5. Any other condition that, in the investigator's opinion, makes the subject unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in plasma Calcitonin Gene-Related Peptide (CGRP) levels between the vestibular migraine group and the healthy control group | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between plasma CGRP levels and clinical factors (disease activity, severity, vestibular function test results, etc.) and the cut-off value for differential diagnosis | — |
Countries
Korea, Republic of
Contacts
Jeonbuk National University Hospital